Free Trial

Smith & Nephew SNATS (NYSE:SNN) Sees Large Volume Increase - What's Next?

Smith & Nephew SNATS logo with Medical background

Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Get Free Report) saw strong trading volume on Wednesday . 1,805,283 shares traded hands during trading, an increase of 122% from the previous session's volume of 812,288 shares.The stock last traded at $30.51 and had previously closed at $29.77.

Analyst Ratings Changes

A number of equities analysts have commented on the company. Canaccord Genuity Group raised their price objective on Smith & Nephew SNATS from $27.00 to $28.00 and gave the stock a "hold" rating in a research note on Thursday, May 1st. UBS Group downgraded Smith & Nephew SNATS from a "buy" rating to a "neutral" rating in a report on Wednesday, March 12th. Hsbc Global Res downgraded Smith & Nephew SNATS from a "strong-buy" rating to a "hold" rating in a report on Friday, April 25th. Finally, HSBC downgraded Smith & Nephew SNATS from a "buy" rating to a "hold" rating in a research note on Friday, April 25th. Six investment analysts have rated the stock with a hold rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $28.00.

Get Our Latest Stock Report on Smith & Nephew SNATS

Smith & Nephew SNATS Trading Up 1.2%

The business has a 50 day moving average of $29.24 and a two-hundred day moving average of $27.37. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.33 and a current ratio of 2.89. The firm has a market capitalization of $13.60 billion, a price-to-earnings ratio of 14.37, a P/E/G ratio of 0.94 and a beta of 0.69.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. J. Goldman & Co LP bought a new stake in Smith & Nephew SNATS during the 4th quarter worth approximately $47,700,000. Goldman Sachs Group Inc. increased its holdings in Smith & Nephew SNATS by 49.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,771,401 shares of the medical equipment provider's stock worth $50,255,000 after purchasing an additional 583,809 shares in the last quarter. Armistice Capital LLC increased its holdings in Smith & Nephew SNATS by 258.1% during the 1st quarter. Armistice Capital LLC now owns 1,769,000 shares of the medical equipment provider's stock worth $50,187,000 after purchasing an additional 1,275,000 shares in the last quarter. Brandes Investment Partners LP increased its holdings in Smith & Nephew SNATS by 11.4% during the 4th quarter. Brandes Investment Partners LP now owns 1,363,039 shares of the medical equipment provider's stock worth $33,504,000 after purchasing an additional 138,994 shares in the last quarter. Finally, Clark Estates Inc. NY increased its holdings in Smith & Nephew SNATS by 6.3% during the 1st quarter. Clark Estates Inc. NY now owns 850,000 shares of the medical equipment provider's stock worth $24,114,000 after purchasing an additional 50,000 shares in the last quarter. 25.64% of the stock is owned by institutional investors and hedge funds.

About Smith & Nephew SNATS

(Get Free Report)

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.

See Also

Should You Invest $1,000 in Smith & Nephew SNATS Right Now?

Before you consider Smith & Nephew SNATS, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith & Nephew SNATS wasn't on the list.

While Smith & Nephew SNATS currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines